Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
M Comabella, K Balashov,
Shohreh Issazadeh-Navikas
, D Smith, H L Weiner, S J Khoury
186
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Cyclophosphamide
100%
Interleukin 12
100%
Methylprednisolone
85%
Interleukin 5
28%
Methotrexate
14%
Peripheral Blood Mononuclear Cell
14%
Keyphrases
Progressive multiple Sclerosis
100%
Methylprednisolone
42%
Methylprednisolone Pulse Therapy
42%
Progressive MS
28%
IFN-γ Production
28%
MS Patients
14%
TGF-β Expression
14%
Intracytoplasmic
14%
Stable Disease
14%
Immune Monitoring
14%
Untreated Patients
14%
Active Disease
14%
Immunology and Microbiology
Cyclophosphamide
100%
Methylprednisolone
85%
Perfosfamide
14%